Hospital
Southern Baptist Hospital of Florida, INC
Southern Baptist Hospital of Florida, INC was paid $3.49M by Medicaid between Mar 2020 and Dec 2024, across 79 billing codes. Its largest line is 99283, emergency room visit (moderate) — 53% of everything it billed.
33Billing provider infoSOUTHERN BAPTIST HOSPITAL OF FLORIDA, INC
JACKSONVILLE, FL 32246
JACKSONVILLE, FL 32246
33aNPI1437823986assigned 08/06/2021
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.49M
24GClaims56,075
24DCodes billed79
24AFirst – last monthMar 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#97 of 163
Median peer was paid$4.77M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 403 | $118.53 | |
| 2021 | 8,973 | $451K | |
| 2022 | 20,460 | $942K | |
| 2023 | 20,517 | $1.53M | |
| 2024incomplete | 5,722 | $567K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 53% | 15,395 | 14,124 | $1.86M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 5,054 | 4,417 | $774K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.6% | 1,218 | 1,042 | $335K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.2% | 2,954 | 2,607 | $285K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.4% | 865 | 730 | $49K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.2% | 269 | 242 | $41K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.1% | 293 | 269 | $39K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 990 | 895 | $34K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 2,440 | 2,195 | $24K |
| 93975 | <1% | 107 | 97 | $12K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,548 | 1,341 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 244 | 209 | $6K |
67 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 253 | $6K |
| 81025 | <1% | 1,663 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 785 | $3K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 55 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 733 | $2K |
| 87081 | <1% | 876 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,000 | $2K |
| 93976 | <1% | 116 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 68 | $877.58 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,077 | $858.70 |
| 83690 | <1% | 729 | $676.47 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 53 | $622.46 |
| 81001 | <1% | 1,860 | $581.49 | |
| 87088 | <1% | 1,262 | $513.52 | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,795 | $500.66 |
| 87631 | <1% | 54 | $429.11 | |
| 74018 | <1% | 54 | $417.81 | |
| 87430 | <1% | 2,020 | $378.74 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 522 | $362.34 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,298 | $274.48 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 321 | $245.61 |
| 73630 | <1% | 16 | $118.32 | |
| 73610 | <1% | 33 | $78.88 | |
| 73110 | <1% | 39 | $78.88 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 707 | $35.55 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 289 | $0.00 |
| 87070 | 0% | 433 | $0.00 | |
| 83735 | 0% | 95 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 760 | $0.00 |
| 84484 | 0% | 486 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 17 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 518 | $0.00 |
| 85652 | 0% | 61 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 33 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 119 | $0.00 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 42 | $0.00 |
| 84704 | 0% | 119 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 548 | $0.00 |
| 83605 | 0% | 33 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 145 | $0.00 |
| 86140 | 0% | 72 | $0.00 | |
| 85730 | 0% | 48 | $0.00 | |
| 82550 | 0% | 12 | $0.00 | |
| 83880 | 0% | 16 | $0.00 | |
| 85379 | 0% | 46 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 129 | $0.00 |
| 82962 | 0% | 74 | $0.00 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 0% | 21 | $0.00 |
| 87077 | 0% | 27 | $0.00 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 0% | 76 | $0.00 |
| 86901 | 0% | 19 | $0.00 | |
| 99292 | 0% | 19 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 382 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 284 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 145 | $0.00 |
| 81003 | 0% | 433 | $0.00 | |
| 80076 | 0% | 311 | $0.00 | |
| 93308 | 0% | 12 | $0.00 | |
| 73130 | 0% | 12 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 21 | $0.00 |
| 87210 | 0% | 177 | $0.00 | |
| 80305 | 0% | 97 | $0.00 | |
| 85610 | 0% | 100 | $0.00 | |
| 69210 | 0% | 35 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 16 | $0.00 |
| 82248 | 0% | 13 | $0.00 | |
| 87186 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOYCE, PHILIP (CHIEF REVENUE OFFICER)
Parent organizationSOUTHERN BAPTIST HOSPITAL OF FLORIDA, INC
| Provider | Location | Paid |
|---|---|---|
| Southern Baptist Hospital of Florida INC | Jacksonville, FL | $87.92M |
| Baptist Medical Center of Nassau INC | Fernandina Beach, FL | $3.46M |
| Southern Baptist Hospital of Florida, INC | Jacksonville, FL | $3.32M |
| Baptist Medical Center of the Beaches, INC | Jacksonville Beach, FL | $3.21M |
| Southern Baptist Hospital of Florida, INC | Fleming Island, FL | $1.70M |
| Southern Baptist Hospital of Florida, INC | Jacksonville, FL | $1.30M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.